The MJFox Foundation have assembled LEAPS team (linked-efforts to accelerate Parkinson’s solutions) to assess and cross-validate the various existing oligomeric and PS129 a-synuclein assays followed by initiation of a round robin where these assays will be used to assess pS129 and Oligomeric α-synuclein levels in well-characterized samples from PD and CT subjects.
Partners:
Hilal A. Lashuel, PhD, EPFL-Lausanne, Switzerland
Jing Zhang, MD, PhD, University of Washington, Seattle, Washington, United States
Omar El-Agnaf, PhD, Hamad Bin Khalifa University, Doha, Qatar,
Peggy Taylor, ScD, BioLegend, Inc., Massachusetts, United States
Brit Mollenhauer, MD, University Medical Center, Goettingen, Germany
Robert Umek, PhD, Meso Scale Discovery, Maryland, United States
Henrik Zetterberg, MD, PhD, University of Gothenburg, Mölndal, Sweden